Biospecimen Repository and Histopathology Service

HomeClinical Trial Laboratory (CTL)Banking Group | Histopathology Service (HPS) | EquipmentRecent Enhancements | Request De-Identified Biospecimens

Director: Chen Liu, MD, PhD

Co-Director: Parisa Javidian, MD

Manager: Kelly Walton

Biospecimen Repository and Histopathology Service 


The Biospecimen Repository and Histopathology Service shared resource (Biorepository) of the Rutgers Cancer Institute of New Jersey is a Cancer Center managed shared resource whose purpose is to support transdisciplinary and translational research through cost-effective, quality controlled tissue collection, biospecimen procurement and processing and cancer clinical trial support.

CAP accreditationThe Biorepository provides tissues for cancer research through a seamless acquisition-processing-distribution pathway. The resource staff also provides collection, processing and shipping for thousands of clinical trial specimens by adhering to specific protocols. Our CLIA licensed histology laboratory delivers state of the art technologies for tissue analysis along with professional tissue examination by board-certified pathologists. The Biorepository follows best practices as dictated by the College of American Pathologists (CAP) guidelines.

Biospecimen Repository and Histopathology TeamThe Biorepository uses state of the art technologies for tissue analysis and professional interpretation under CAP guidelines. In addition, the Biorepository serves as an “honest broker” and maintains the chain of custody for patient samples and their clinical annotations.

The Biorepository is comprised of three divisions:

The Biorepository Lab Divisions support clinical trials, tissue banking and basic science by collecting, cataloging, processing, storing and distributing bio-specimens from human subjects while archiving useful medical information along with written patient consents. Each of the divisions is distinct, yet they cooperate to provide a seamless workflow and unparalleled service, and are operated by highly qualified technologists and strong leadership.



The Biospecimen Repository and Histopathology Service shared resource of Rutgers Cancer Institute of New Jersey is a specialized service facility that supports the cancer research efforts of our members.

This facility is supported primarily by the Cancer Center Support Grant (CCSG) from the National Cancer Institute.  Additional support may be provided from other sources, such as chargeback systems, institutional funding and/or other grants. The support from the CCSG allows the facility to provide benefits to Cancer Center members, such as ensured access to services or subsidies to user rates.

Please remember to acknowledge the valuable services provided by the Biospecimen Repository Service shared resource in your research papers, publications and grant applications. The following acknowledgement statement is recommended:

"This research was supported by the Biospecimen Repository Service Shared Resource of Rutgers Cancer Institute of New Jersey (P30CA072720)."

(Note: please also consider including the names of individuals from the shared resource if they provided any intellectual input or additional effort.)


precision medicine at Rutgers Cancer Institute












Proud member of
Big Ten Cancer Research Consortium



Rutgers Health